Find / Register for a Course



New Treatments in Chronic Liver Disease: Pre-Course


March 31, 2017
Estancia La Jolla Hotel
La Jolla, California

Overview

We will review the virology, genotypes, modes of infection of HCV and characteristics of the clinical illness caused by acute and chronic infections. Tests for HCV, including PCR assays and genotyping, interpretations and indications for liver biopsies and complications of cirrhosis will all be discussed.

We will show how to initiate and monitor patients during treatment with simeprevir and sofosbuvir, manage side effects of therapy and deal with various patient populations including African Americans, HIV-coinfected and ESLD patients. Lastly, new drugs in development including protease inhibitors, other nucleoside and non-nucleoside polymerase inhibitors, NS5A inhibitors, and other novel agents will be discussed.

Conference Highlights

  • Update on HCV Diagnostics
  • Update on Current therapy with all-oral regimens
  • Case Presentation, Discussion and Q&A
    • Selection of Treatment
    • Cirrhosis: Who to Treat
    • Treatment of Special Populations
  • Networking and Opportunity to view exhibits
  • Claim up to 3.5 AMA PRA Category 1 Credit(s)™

Target Audience

  • Hepatologists
  • Gastroenterologists
  • Infectious Disease Specialists
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Residents/Fellows
  • Others desiring an update in these specialty areas




Download Brochure »

For more information contact:

Scripps Conference Services & CME
11025 N. Torrey Pines Rd. Ste 200
Maildrop: SCRC200
LaJolla, CA 92037

Phone: (858) 652-5400
Email: med.edu@scrippshealth.org